Publications by authors named "Timon Hansen"

Claim this Profile
A
A new screening tool for early recognition of ATTRv polyneuropathy in clinical practice: AmyloScan.
Juliane Sachau, Lena Rhode, Maike F Dohrn, Jan Vollert, Stefanie Rehm, Timon Hansen

J Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elotuzumab in Combination With Dose Reduced IMiDs and Dexamethasone for AL Amyloidosis Patients With Relapsed/Refractory Plasma Cell Dyscrasia and Advanced Organ Involvement.
Tobias Dittrich, Timon Hansen, Christoph R Kimmich, Kaya Veelken, Anna Jauch

Am J Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosing AL and ATTR Amyloid Cardiomyopathy: A Multidisciplinary Approach.
Fabian Aus dem Siepen, Timon Hansen

J Clin Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21.
Christoph R Kimmich, Tobias Terzer, Axel Benner, Timon Hansen, Alexander Carpinteiro

Am J Hematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Efstathios Kastritis, Giovanni Palladini, Monique C Minnema, Ashutosh D Wechalekar, Arnaud Jaccard, Timon Hansen

N Engl J Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies.
Levin Schriewer, Kerstin Schütze, Katharina Petry, Julia Hambach, William Fumey, Timon Hansen

Theranostics· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria.
Christoph R Kimmich, Tobias Terzer, Axel Benner, Tobias Dittrich, Kaya Veelken, Timon Hansen

Blood· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs).
Julia Hambach, Kristoffer Riecken, Sophia Cichutek, Kerstin Schütze, Birte Albrecht, Timon Hansen

Cells· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma.
Hans Salwender, Uta Bertsch, Katja Weisel, Jan Duerig, Christina Kunz, Timon Hansen

BMC Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p.
Sandy W Wong, Ute Hegenbart, Giovanni Palladini, Gunjan L Shah, Heather J Landau, Timon Hansen

Clin Lymphoma Myeloma Leuk· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Living with the burden of relapse in multiple myeloma from the patient and physician perspective.
Cyrille Hulin, Timon Hansen, Louise Heron, Rachel Pughe, Matthew Streetly

Leuk Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.
Nicolaus Kröger, Anita Badbaran, Tatjana Zabelina, Francis Ayuk, Christine Wolschke, Timon Hansen

Biol Blood Marrow Transplant· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis